Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 612823, 9 pages
http://dx.doi.org/10.1155/2014/612823
Research Article

Disruption of HPV16-E7 by CRISPR/Cas System Induces Apoptosis and Growth Inhibition in HPV16 Positive Human Cervical Cancer Cells

1Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China
2Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China
3Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China

Received 30 April 2014; Accepted 15 June 2014; Published 20 July 2014

Academic Editor: Xin Ming

Copyright © 2014 Zheng Hu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. P. Armstrong and D. Pharm, “Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types,” Journal of Managed Care Pharmacy, vol. 16, no. 3, pp. 217–230, 2010. View at Google Scholar
  2. G. M. Clifford, J. S. Smith, and M. Plummer, “Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis,” British Journal of Cancer, vol. 88, no. 1, pp. 63–73, 2003. View at Google Scholar
  3. C. Talora, D. C. Sgroi, and C. P. Crum, “Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation,” Genes & Development, vol. 16, no. 17, pp. 2252–2263, 2002. View at Publisher · View at Google Scholar
  4. C. J. Lee, E. J. Suh, H. T. Kang et al., “Induction of senescence-like state and suppression of telomerase activity through inhibition of HPV E6/E7 gene expression in cells immortalized by HPV16 DNA,” Experimental Cell Research, vol. 277, no. 2, pp. 173–182, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. C. H. Chung and M. L. Gillison, “Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications,” Clinical Cancer Research, vol. 15, no. 22, pp. 6758–6762, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Barrangou, C. Fremaux, H. Deveau et al., “CRISPR provides acquired resistance against viruses in prokaryotes,” Science, vol. 315, no. 5819, pp. 1709–1712, 2007. View at Publisher · View at Google Scholar
  7. I. Katic and H. Großhans, “Targeted heritable mutation and gene conversion by Cas9-CRISPR in Caenorhabditis elegans,” Genetics, vol. 195, no. 3, pp. 1173–1176, 2013. View at Publisher · View at Google Scholar
  8. W. Y. Hwang, Y. Fu, D. Reyon et al., “Efficient genome editing in zebrafish using a CRISPR-Cas system,” Nature Biotechnology, vol. 31, no. 3, pp. 227–229, 2013. View at Google Scholar
  9. P. Mali, L. Yang, and K. M. Esvelt, “RNA-guided human genome engineering via Cas9,” Science, vol. 339, no. 6121, pp. 823–826, 2013. View at Google Scholar
  10. E. Heidenreich, R. Novotny, B. Kneidinger et al., “Non-homologous end joining as an important mutagenic process in cell cycle-arrested cells,” The EMBO Journal, vol. 22, no. 9, pp. 2274–2283, 2003. View at Google Scholar
  11. M. S. Bhakta and D. J. Segal, “The generation of zinc finger proteins by modular assembly,” Methods in Molecular Biology, vol. 649, pp. 3–30, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. H. J. Kim and H. J. Lee, “Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly,” Genome Research, vol. 19, no. 7, pp. 1279–1288, 2009. View at Google Scholar
  13. H. zur Hausen, “Papillomaviruses and cancer: from basic studies to clinical application,” Nature Reviews Cancer, vol. 2, no. 5, pp. 342–350, 2002. View at Publisher · View at Google Scholar
  14. A. L. Jonson, L. M. Rogers, S. Ramakrishnan et al., “Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer,” Gynecologic Oncology, vol. 111, no. 2, pp. 356–364, 2008. View at Google Scholar
  15. D. Castanotto and J. J. Rossi, “The promises and pitfalls of RNA-interference-based therapeutics,” Nature, vol. 457, no. 7228, pp. 426–433, 2009. View at Google Scholar
  16. K. Rothkamm, I. Krüger, L. H. Thompson, and M. Löbrich, “Pathways of DNA double-strand break repair during the mammalian cell cycle,” Molecular and Cellular Biology, vol. 23, no. 16, pp. 5706–5715, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Fu, J. A. Foden, and C. Khayter, “High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells,” Nature Biotechnology, vol. 31, no. 9, pp. 822–826, 2013. View at Publisher · View at Google Scholar
  18. C. Mussolino and T. Cathomen, “RNA guides genome engineering,” Nature Biotechnology, vol. 31, no. 3, pp. 208–209, 2013. View at Google Scholar
  19. F. A. Ran, P. D. Hsu, C. Y. Lin et al., “Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity,” Cell, vol. 154, no. 6, pp. 1380–1389, 2013. View at Publisher · View at Google Scholar · View at Scopus